WDR5 inhibition halts metastasis dissemination by repressing the mesenchymal phenotype of breast cancer cells

被引：0
作者：
Simona Punzi
Chiara Balestrieri
Carolina D’Alesio
Daniela Bossi
Gaetano Ivan Dellino
Elena Gatti
Giancarlo Pruneri
Carmen Criscitiello
Giulia Lovati
Marine Meliksetyan
Alessandro Carugo
Giuseppe Curigliano
Gioacchino Natoli
Pier Giuseppe Pelicci
Luisa Lanfrancone
机构：
[1] European Institute of Oncology IRCCS,Department of Experimental Oncology
[2] Humanitas University,Present address: Department of Internal Medicine and Medical Specialties (Di.M.I)
[3] Humanitas Clinical and Research Institute,Department of Oncology and Hemato
[4] University of Genova,Oncology
[5] Present address: Institute of Oncology Research (IOR),Department of Pathology, Biobank for Translational Medicine Unit
[6] University of Milan,Division of Early Drug Development for Innovative Therapy
[7] European Institute of Oncology,Institute for Applied Cancer Science
[8] IRCCS,undefined
[9] Present address: Istituto Nazionale dei Tumori – Fondazione IRCCS,undefined
[10] European Institute of Oncology IRCCS,undefined
[11] UT MD Anderson Cancer Cente,undefined
来源：
Breast Cancer Research | / 21卷
关键词：
Breast cancer; EMT; Metastasis; TGFβ1; WDR5;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 295 条
  • [1] Ginsburg O(2017)The global burden of women's cancers: a grand challenge in global health Lancet 389 847-860
  • [2] Bray F(2016)EMT: 2016 Cell. 166 21-45
  • [3] Coleman MP(2015)ZEB1-associated drug resistance in cancer cells is reversed by the class I HDAC inhibitor mocetinostat EMBO Mol Med 7 831-847
  • [4] Vanderpuye V(2016)EMT, cell plasticity and metastasis Cancer Metastasis Rev 35 645-654
  • [5] Eniu A(2006)Complex networks orchestrate epithelial-mesenchymal transitions Nat Rev Mol Cell Biol 7 131-142
  • [6] Kotha SR(2011)Tracking the intermediate stages of epithelial-mesenchymal transition in epithelial stem cells and cancer Cell Cycle 10 2865-2873
  • [7] Nieto MA(2009)Epithelial-mesenchymal transition in development and cancer Future Oncol 5 1129-1143
  • [8] Huang RY(2010)Smad signaling is required to maintain epigenetic silencing during breast cancer progression Cancer Res 70 968-978
  • [9] Jackson RA(2017)A TGFbeta-PRMT5-MEP50 axis regulates cancer cell invasion through histone H3 and H4 arginine methylation coupled transcriptional activation and repression Oncogene. 36 373-386
  • [10] Thiery JP(2016)Roles and epigenetic regulation of epithelial-mesenchymal transition and its transcription factors in cancer initiation and progression Cell Mol Life Sci 73 4643-4660
12345678910